ACYCLOVIR OINT (CCHP2017)

Similar documents
ACYCLOVIR OINT (CCHP2017)

ACYCLOVIR OINT (CCHP2017)

ACYCLOVIR OINT (CCHP2017)

ACYCLOVIR OINT (CCHP2017)

2015 Chinese Community Health Plan Senior Program (HMO) Step Therapy Criteria Last Updated 11/1/2015

Plan Year CCHP Senior Program (HMO) Step Therapy Criteria (ST)

2017 Step Therapy Criteria

ANGIOTENSIN RECEPTOR BLOCKERS STEP THERAPY

ALLERGIC CONJUNCTIVITIS AGENTS

ALPHA BLOCKERS. Products Affected. Details. Step 2: RAPAFLO 4 MG CAPSULE. Step 1: alfuzosin extended release tablet doxazosin tablet

ALZHEIMER'S DRUGS. Details. Step 2: Exelon Patch 13.3 mg/24 hour transdermal Exelon Patch 4.6 mg/24 hr transdermal

ANTICONVULSANTS. Details

ANTICONVULSANTS. Details

Santa Clara Family Health Plan Cal MediConnect Formulary. List of Step Therapy Requirements Effective: 12/01/ E

ANTICONVULSANTS. Details

ANTIDEPRESSANTS. Details. dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet. Criteria

2019 PDP Basic Step Therapy Document

Step Therapy Requirements

Step Therapy Requirements. Effective: 05/01/2018

ANTICONVULSANTS. Details

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Step Therapy Requirements. Effective: 11/01/2018

FirstCarolinaCare Insurance Company. Step Therapy Requirements

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

2018 PDP Premier Step Therapy Document September 2018 Y0114_18_33144_I_009

Drugs That Require Step Therapy (ST) Step Therapy Medications

2018 Step Therapy FID 18088

ANTICONVULSANT STEP THERAPY

2019 Simply Step Therapy Document

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO) and Stride SM Value Rx Plus (HMO) Step Therapy Requirements

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

Harvard Pilgrim Health Care Stride SM Basic Rx (HMO), Stride SM Value Rx (HMO), Stride SM Value Rx Plus (HMO) and Stride SM Gain Rx (HMO)

2015 Step Therapy Prior Authorization Medical Necessity Guidelines

Step Therapy Requirements

2018 STEP THERAPY CRITERIA UCare Connect (SNBC) MinnesotaCare Prepaid Medical Assistance Program (PMAP) Minnesota Senior Care Plus (MSC+)

JANUVIA 50 MG TABLET BYDUREON 2 MG/0.65 ML JARDIANCE 10 MG TABLET SUBCUTANEOUS PEN INJECTOR JARDIANCE 25 MG TABLET BYDUREON BCISE 2 MG/0.

Step Therapy Requirements. Effective: 1/1/2019

ANTIDIABETIC AGENTS - MISCELLANEOUS

AMANTADINE ER. Products Affected Step 2: OSMOLEX ER 129 MG TABLET, EXTENDED RELEASE OSMOLEX ER 193 MG TABLET, Details

ANTIDIABETIC AGENTS - MISCELLANEOUS

Simply Step Therapy Document September 2018 Y0114_18_33074_I_009

Step Therapy Requirements

ANTIDIABETIC AGENTS - MISCELLANEOUS

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

Step Therapy Medications

ALOGLIPTIN STEP. Step Therapy Requirements Effective April 1, 2018

ALOGLIPTIN STEP. Step Therapy Requirements Effective June 1, 2018

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 04/01/2019

ADHD STIMULANTS-S(SHC)

2018 Step Therapy Criteria (List of Step Therapy Criteria)

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

WELLCARE/ OHANA HEALTH PLAN 2015 STEP THERAPY CRITERIA (No Changes Made Since: 08/2015)

2018 Step Therapy Criteria

HARVARD PILGRIM HEALTH CARE RECOMMENDED MEDICATION REQUEST GUIDELINES

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR

COLCRYS-PST. Products Affected Step 1: Mitigare 0.6 mg capsule. Details. Step 2: Colcrys 0.6 mg tablet

CRITERIA Trial of two generic formulary products from the following: atomoxetine or ADHD stimulant medication.

5-ASA. Products Affected Dipentum 250 mg capsule. Details. Lialda 1.2 gram tablet,delayed release

2019 GRS Premier Step Therapy Document

COLCRYS-PST. Products Affected Step 1: Mitigare 0.6 mg capsule. Details. Step 2: Colcrys 0.6 mg tablet

Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria

AETNA BETTER HEALTH January 2017 Formulary Change(s)

SmithRx Standard Formulary Step Therapy List

2018 GRS Premier Step Therapy Document. September 2018 Y0114_18_33177_I_010

VNSNY CHOICE FIDA Complete Step Therapy Requirements. Effective: 01/01/2017

BYSTOLIC. Products Affected Step 2: BYSTOLIC 10 MG TABLET BYSTOLIC 2.5 MG TABLET. Details BYSTOLIC 20 MG TABLET BYSTOLIC 5 MG TABLET

DPP4 INHIBITORS. Details. Step Therapy Criteria Health Alliance Plan 2019 Date Effective: 04/01/2019

2018 WPS MedicareRx Plan (PDP) Step Therapy

DPP4 INHIBITORS. Products Affected Step 2: Janumet 50 mg-1,000 mg tablet Janumet 50 mg-500 mg tablet Januvia 100 mg tablet Januvia 25 mg tablet

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

2018 AlohaCare Advantage Plus Formulary (HMO SNP) Drugs with Step Therapy Requirements

FirstCarolinaCare Insurance Company Step Therapy Requirements

ALPHA GLUCOSIDASE INHIBITOR THERAPY

Contents ALPHA BLOCKERS... 3 COLCRYS-PST... 4 DPP-4 INHIBITORS-PST... 5 HIGH RISK MEDICATIONS - SEDATIVE HYPNOTICS... 6

ALPHA BLOCKERS. Products Affected Step 1: Details. Step 2: Rapaflo 4 mg capsule Rapaflo 8 mg capsule

Drugs That Require Step Therapy (ST) Step Therapy Medications

STEP THERAPY CRITERIA

Drugs That Require Step Therapy (ST) Step Therapy Medications

2018 Step Therapy (ST) Criteria

Alprazolam 0.25mg, 0.5mg, 1mg tablets

Attention: Behavioral Health Providers, Pharmacists and Prescribers N.C. Medicaid and N.C. Health Choice Preferred Drug List Changes - UPDATE

Transcription:

ACYCLOVIR OINT (CCHP2017) acyclovir 5 % topical ointment Step Therapy requires trial of one (1) of the following: oral generic acyclovir, oral generic famciclovir, oral generic valacyclovir. 1

ALPHAGAN (CCHP2017) Alphagan P 0.1 % eye drops Step Therapy requires trial of brimonidine 0.15%. 2

ANTIDEPRESSANT_NVT 2017 desvenlafaxine ER 100 mg tablet,extended release 24 hr desvenlafaxine ER 50 mg tablet,extended release 24 hr duloxetine 40 mg capsule,delayed release Fetzima 120 mg capsule,extended release Fetzima 20 mg (2)-40 mg (26) capsule,extended release,24 hr,dose pack Fetzima 20 mg capsule,extended release Fetzima 40 mg capsule,extended release Fetzima 80 mg capsule,extended release fluvoxamine ER 100 mg capsule,extended release 24 hr fluvoxamine ER 150 mg capsule,extended release 24 hr Trintellix 10 mg tablet Trintellix 20 mg tablet Trintellix 5 mg tablet Viibryd 10 mg (7)-20 mg (23) tablets in a dose pack Viibryd 10 mg tablet Viibryd 20 mg tablet Viibryd 40 mg tablet Step Therapy requires trial of one of the following generic SSRI's in previous 120 days: escitalopram, sertraline, fluoxetine, citalopram, paroxetine or fluvoxamine. If request is for duloxetine, step not required for diabetic peripheral neuropathy, fibromyalgia, or chronic musculoskeletal pain. 3

ARANESP_NVT 2016 Aranesp 10 mcg/0.4 ml (in polysorbate) Aranesp 100 mcg/0.5 ml (in polysorbate) Aranesp 100 mcg/ml (in polysorbate) Injection Aranesp 150 mcg/0.3 ml (in polysorbate) Aranesp 200 mcg/0.4 ml (in polysorbate) Aranesp 200 mcg/ml (in polysorbate) Injection Aranesp 25 mcg/0.42 ml (in polysorbate) Aranesp 25 mcg/ml (in polysorbate) Injection Aranesp 300 mcg/0.6 ml (in polysorbate) Aranesp 300 mcg/ml (in polysorbate) Injection Aranesp 40 mcg/0.4 ml (in polysorbate) Aranesp 40 mcg/ml (in polysorbate) Injection Aranesp 500 mcg/ml (in polysorbate) Aranesp 60 mcg/0.3 ml (in polysorbate) Aranesp 60 mcg/ml (in polysorbate) Injection Step Therapy requires trial of PROCRIT or EPOGEN 4

ARICEPT 23_NVT 2015 donepezil 23 mg tablet Step Therapy requires trial of donepezil 10mg in previous 120 days. 5

DRY EYE OTC (CCHP 2018) Restasis 0.05 % eye drops in a dropperette Restasis MultiDose 0.05 % eye drops Step Therapy requires trial of OTC artificial tears. 6

ESTRING_NVT 2016 Estring 2 mg (7.5 mcg/24 hour) vaginal ring Step Therapy requires trial of PREMARIN VAGINAL CREAM in previous 120 days. 7

NAMZARIC_NVT Namzaric 14 mg-10 mg capsule sprinkle,extended release Namzaric 21 mg-10 mg capsule sprinkle,extended release Namzaric 28 mg-10 mg capsule sprinkle,extended release Namzaric 7 mg-10 mg capsule sprinkle,extended release Namzaric 7/14/21/28 mg-10 mg capsule,sprinkle,er 24hr,dose pack Patient has tried or was intolerant to donepezil and memantine. 8

OPHTHALMIC ANTI-INFECTIVES_NVT 2015 Besivance 0.6 % eye drops,suspension gatifloxacin 0.5 % eye drops Step Therapy requires trial of one of the following ciprofloxacin, levofloxacin, ofloxacin, VIGAMOX or MOXEZA in previous 120 days. 9

PANCREATIC ENZYMES_NVT 2015 Pancreaze 10,500 unit-35,500 unit-61,500 unit capsule,delayed release Pancreaze 16,800 unit-56,800 unit-98,400 unit capsule,delayed release Pancreaze 2,600 unit-6,200 unit-10,850 unit capsule,delayed release Pancreaze 21,000 unit-54,700 unit-83,900 unit capsule,delayed release Pancreaze 4,200 unit-14,200 unit-24,600 unit capsule,delayed release Step Therapy requires trial of CREON in previous 120 days. 10

ULORIC_NVT 2015 Uloric 40 mg tablet Uloric 80 mg tablet Step Therapy requires trial of allopurinol in previous 120 days. 11

VANCOCIN_NVT vancomycin 125 mg capsule vancomycin 250 mg capsule Step Therapy requires trial of metronidazole in previous 120 days. If for C. difficile-associate diarrhea, step therapy not required if for severe or complicated disease. 12

ZADITOR OTC (CCHP2017) olopatadine 0.1 % eye drops Step 3: olopatadine 0.2 % eye drops Pazeo 0.7 % eye drops Step Therapy requires trial of OTC zaditor/ketotifen for olopatadine ophth soln. Trial of olopatadine ophth soln required for PATADAY/PAZEO. 13

INDEX A acyclovir 5 % topical ointment... 1 Alphagan P 0.1 % eye drops... 2 Aranesp 10 mcg/0.4 ml (in polysorbate)... 4 Aranesp 100 mcg/0.5 ml (in polysorbate)... 4 Aranesp 100 mcg/ml (in polysorbate) Injection... 4 Aranesp 150 mcg/0.3 ml (in polysorbate)... 4 Aranesp 200 mcg/0.4 ml (in polysorbate)... 4 Aranesp 200 mcg/ml (in polysorbate) Injection... 4 Aranesp 25 mcg/0.42 ml (in polysorbate)... 4 Aranesp 25 mcg/ml (in polysorbate) Injection... 4 Aranesp 300 mcg/0.6 ml (in polysorbate)... 4 Aranesp 300 mcg/ml (in polysorbate) Injection... 4 Aranesp 40 mcg/0.4 ml (in polysorbate)... 4 Aranesp 40 mcg/ml (in polysorbate) Injection... 4 Aranesp 500 mcg/ml (in polysorbate)... 4 Aranesp 60 mcg/0.3 ml (in polysorbate)... 4 Aranesp 60 mcg/ml (in polysorbate) Injection... 4 B Besivance 0.6 % eye drops,suspension... 9 D desvenlafaxine ER 100 mg tablet,extended release 24 hr... 3 desvenlafaxine ER 50 mg tablet,extended release 24 hr... 3 donepezil 23 mg tablet... 5 duloxetine 40 mg capsule,delayed release.. 3 E Estring 2 mg (7.5 mcg/24 hour) vaginal ring... 7 F Fetzima 120 mg capsule,extended release.. 3 Fetzima 20 mg (2)-40 mg (26) capsule,extended release,24 hr,dose pack 3 Fetzima 20 mg capsule,extended release... 3 Fetzima 40 mg capsule,extended release... 3 Fetzima 80 mg capsule,extended release... 3 fluvoxamine ER 100 mg capsule,extended release 24 hr... 3 fluvoxamine ER 150 mg capsule,extended release 24 hr... 3 G gatifloxacin 0.5 % eye drops... 9 N Namzaric 14 mg-10 mg capsule sprinkle,extended release... 8 Namzaric 21 mg-10 mg capsule sprinkle,extended release... 8 Namzaric 28 mg-10 mg capsule sprinkle,extended release... 8 Namzaric 7 mg-10 mg capsule sprinkle,extended release... 8 Namzaric 7/14/21/28 mg-10 mg capsule,sprinkle,er 24hr,dose pack... 8 O olopatadine 0.1 % eye drops... 13 olopatadine 0.2 % eye drops... 13 P Pancreaze 10,500 unit-35,500 unit-61,500 unit capsule,delayed release... 10 Pancreaze 16,800 unit-56,800 unit-98,400 unit capsule,delayed release... 10 Pancreaze 2,600 unit-6,200 unit-10,850 unit capsule,delayed release... 10 Pancreaze 21,000 unit-54,700 unit-83,900 unit capsule,delayed release... 10 Pancreaze 4,200 unit-14,200 unit-24,600 unit capsule,delayed release... 10 Pazeo 0.7 % eye drops... 13 14

R Restasis 0.05 % eye drops in a dropperette. 6 Restasis MultiDose 0.05 % eye drops... 6 T Trintellix 10 mg tablet... 3 Trintellix 20 mg tablet... 3 Trintellix 5 mg tablet... 3 U Uloric 40 mg tablet... 11 Uloric 80 mg tablet... 11 V vancomycin 125 mg capsule... 12 vancomycin 250 mg capsule... 12 Viibryd 10 mg (7)-20 mg (23) tablets in a dose pack... 3 Viibryd 10 mg tablet... 3 Viibryd 20 mg tablet... 3 Viibryd 40 mg tablet... 3 15